Cite
HARVARD Citation
Lee, Y. et al. (2019). Efficacy and safety of PAC‐14028 cream – a novel, topical, nonsteroidal, selective TRPV1 antagonist in patients with mild‐to‐moderate atopic dermatitis: a phase IIb randomized trial. British journal of dermatology. pp. 1030-1038. [Online].